LR04 + LR05 + LP01™ + LP02 + BS01™ (BIFIVIR)
Allergy & Immunology
Immune stimulation / Respiratory tract infections
Enhances natural immunity
Reduces risk of respiratory infection
Inhibits intestinal and respiratory pathogens
1, 2) LR04 2.5 billion CFU + LR05 2.5 billion CFU + LP01 2.5 billion CFU + LP02 2.5 billion CFU + BS01 5 billion CFU + FOS or GOS
Single strain
Blend
Finished dosage form
1) Pregliasco F. et al. A New Chance of Preventing Winter Diseases by the Administration of Symbiotic Formulations. Journal of Clinical Gastroenterology, 2008; 42(2): 224-233.
2) Belcaro G. et al. Prevention of flu episodes with colostrum and Bifivir compared with vaccination: an epidemiological, registry study. Panminerva Medica 2010;52:269-75.
Internal data on immune stimulation and anti-pathogen activity available upon request for certain strains
1) Pregliasco F. et al. A New Chance of Preventing Winter Diseases by the Administration of Symbiotic Formulations. Journal of Clinical Gastroenterology, 2008; 42(2): 224-233. Doi 10.1097/MCG.0b013e31817e1c91
2) Belcaro G et al. Prevention of flu episodes with colostrum and Bifivir compared with vaccination: an epidemiological, registry study. Panminerva Med. 2010 Dec;52(4):269-75. PMID: 21183886.
Internal data on immune stimulation and anti-pathogen activity available upon request for certain strains
